![Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors | BMC Infectious Diseases | Full Text Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors | BMC Infectious Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-023-08448-w/MediaObjects/12879_2023_8448_Fig4_HTML.png)
Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors | BMC Infectious Diseases | Full Text
![More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands - The Lancet Regional Health – Europe More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands - The Lancet Regional Health – Europe](https://www.thelancet.com/cms/asset/a73ff9b8-dea5-48bd-8b2c-d3ac4908c6dc/gr1.jpg)
More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands - The Lancet Regional Health – Europe
![Vaccines | Free Full-Text | Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study Vaccines | Free Full-Text | Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study](https://www.mdpi.com/vaccines/vaccines-11-01409/article_deploy/html/images/vaccines-11-01409-g001.png)
Vaccines | Free Full-Text | Determinants of COVID-19 Vaccine Uptake in The Netherlands: A Nationwide Registry-Based Study
![Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial - Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -](https://www.thelancet.com/cms/asset/3b19b20c-8a5a-43c9-80d5-abbcb3039e22/gr1.jpg)
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -
![Booster vaccinations prove useful for people with transplanted kidney - Immune response emerges after multiple shots - Radboudumc Booster vaccinations prove useful for people with transplanted kidney - Immune response emerges after multiple shots - Radboudumc](https://www.radboudumc.nl/getmedia/30ada281-b438-4475-bdb2-090aa705b63b/iStock-1287172757.jpg.aspx?width=500&height=333&ext=.jpg)
Booster vaccinations prove useful for people with transplanted kidney - Immune response emerges after multiple shots - Radboudumc
![Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study - ScienceDirect Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1201971223005349-gr1.jpg)
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study - ScienceDirect
![Vaccines | Free Full-Text | COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects Vaccines | Free Full-Text | COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects](https://pub.mdpi-res.com/vaccines/vaccines-10-01223/article_deploy/html/images/vaccines-10-01223-g001-550.jpg?1659772982)